journal article·2014-02

Poly (ε‐caprolactone) scaffolds functionalized by grafting NGF and GRGD promote growth and differentiation of PC12 cells

Tze‐Wen Chung, Dar‐Ming Lai, Shin‐Der Chen, Ya‐I Lin

Publisher page

Abstract

Poly(ε‐caprolactone) (PCL) scaffolds functionalized by grafting nerve growth factor (NGF) and Asp‐Arg‐Gly‐Asp (GRGD)(PCL‐NGF/GRGD) for neural tissue engineering. The influences of PCL‐NGF/GRGD scaffolds on the growth and differentiation of PC12 cells were investigated. The successfully grafting NGF and GRGD into PCL‐CS scaffold were verified by FTIR spectra. The densities of GRGD and NGF in the scaffolds were about 2.10×10−1 μmol/cm2 and 1.51×10−3 nmol/cm2. Growths of PC12 cells in PCL‐GRGD and PCL/NGF‐GRGD scaffolds via MTS measurements were significantly higher (p < 0.01, n = 4) than that in PCL‐CS or PCL‐NGF ones for three days of cultivation that was consistent with SEM observations. Moreover, the differentiation of PC12 cells, induced by NGF at 50 ng/mL for four days, in PCL‐NGF/GRGD scaffolds were qualitatively more numbers and longer outgrowth of neurites than those in PCL‐CS, PCL‐GRGD, and PCL‐NGF ones by SEM observations. The synergistic effects of grafting both NGF and GRGD ligands to PCL‐CS scaffolds on the growth and differentiation of PC12 cells provide a new biomaterial for neural tissue engineering. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 315–323, 2014.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nerve injury and regeneration · Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical and Materials Engineering National Yunlin University of Science and Technology Dou‐Liu Yun‐Lin 640 Taiwan, ROC

Department of Surgery National Taiwan University Hospital National Taiwan University College of Medicine Taipei Taiwan, ROC

References (33)

Show source-provided references
1. 10.1016/j.brainresrev.2004.11.00210.1016/j.brainresrev.2004.11.002 ↗
2. 10.1016/S0959-4388(99)00066-510.1016/S0959-4388(99)00066-5 ↗
3. 10.1146/annurev.bioeng.5.011303.12073110.1146/annurev.bioeng.5.011303.120731 ↗
4. 10.1055/s-2007-100640710.1055/s-2007-1006407 ↗
5. 10.1179/01616410422501379810.1179/016164104225013798 ↗
6. 10.1097/00019052-200312000-0001110.1097/00019052-200312000-00011 ↗
7. 10.1016/j.resp.2009.08.01510.1016/j.resp.2009.08.015 ↗
8. 10.1002/jbm.a.3022510.1002/jbm.a.30225 ↗
9. 10.1002/jbm.a.3104710.1002/jbm.a.31047 ↗
10. 10.1046/j.1469-7580.1999.19410001.x10.1046/j.1469-7580.1999.19410001.x ↗
11. 10.1146/annurev.neuro.24.1.67710.1146/annurev.neuro.24.1.677 ↗
12. 10.1146/annurev.neuro.24.1.121710.1146/annurev.neuro.24.1.1217 ↗
13. 10.1016/0092-8674(91)90149-S10.1016/0092-8674(91)90149-S ↗
14. 10.1126/science.185054910.1126/science.1850549 ↗
15. 10.1016/S0304-3940(03)00915-710.1016/S0304-3940(03)00915-7 ↗
16. 10.1016/j.biomaterials.2009.05.03710.1016/j.biomaterials.2009.05.037 ↗
17. 10.1089/ten.2005.11.110.1089/ten.2005.11.1 ↗
18. 10.1016/0968-0004(91)90096-E10.1016/0968-0004(91)90096-E ↗
19. 10.1096/fj.02-0564fje10.1096/fj.02-0564fje ↗
20. 10.1016/S0142-9612(03)00361-210.1016/S0142-9612(03)00361-2 ↗
21. 10.1016/S1389-1723(04)70221-210.1016/S1389-1723(04)70221-2 ↗
22. 10.1021/bm070266z10.1021/bm070266z ↗
23. 10.1016/S0142-9612(02)00231-410.1016/S0142-9612(02)00231-4 ↗
24. 10.1002/jbm.b.3114610.1002/jbm.b.31146 ↗
25. 10.1007/s10856-009-3876-010.1007/s10856-009-3876-0 ↗
26. 10.1002/jbm.a.3103610.1002/jbm.a.31036 ↗
27. 10.1007/s10856-008-3671-310.1007/s10856-008-3671-3 ↗
28. 10.1016/j.actbio.2009.03.00910.1016/j.actbio.2009.03.009 ↗
29. 10.1523/JNEUROSCI.02-08-01157.198210.1523/JNEUROSCI.02-08-01157.1982 ↗
30. 10.3109/02652048.2010.48410410.3109/02652048.2010.484104 ↗
31. 10.1002/cne.2051810.1002/cne.20518 ↗
32. 10.1016/j.biomaterials.2010.09.02310.1016/j.biomaterials.2010.09.023 ↗
33. Use new PLGL‐RGD‐NGF nerve conduits for promoting peripheral nerve regeneration